NUF2 and clear cell renal carcinoma: Many reports have identified NUF2 as an oncogene in various cancers, including clear cell renal cell carcinoma (Lin et al., 2022), melanoma (Wang et al., 2022), and breast cancer (Lv et al., 2020).